Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$123.78 - $142.11 $677,571 - $777,910
5,474 New
5,474 $728,000
Q1 2023

May 12, 2023

SELL
$131.53 - $155.76 $575,969 - $682,073
-4,379 Reduced 47.27%
4,884 $690,000
Q4 2022

Feb 13, 2023

SELL
$123.31 - $157.26 $537,261 - $685,181
-4,357 Reduced 31.99%
9,263 $1.45 Million
Q3 2022

Nov 10, 2022

BUY
$121.77 - $141.1 $1.66 Million - $1.92 Million
13,620 New
13,620 $1.66 Million
Q2 2022

Aug 04, 2022

SELL
$127.07 - $145.39 $3.12 Million - $3.57 Million
-24,541 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$129.09 - $164.35 $3.17 Million - $4.03 Million
24,541 New
24,541 $3.36 Million
Q2 2021

Aug 13, 2021

SELL
$126.66 - $141.48 $1.26 Million - $1.41 Million
-9,980 Closed
0 $0
Q4 2020

Feb 09, 2021

BUY
$112.7 - $128.05 $236,670 - $268,905
2,100 Added 26.65%
9,980 $1.19 Million
Q3 2020

Nov 16, 2020

BUY
$107.05 - $130.01 $843,554 - $1.02 Million
7,880 New
7,880 $902,000
Q2 2020

Aug 06, 2020

SELL
$73.34 - $122.61 $1.86 Million - $3.11 Million
-25,400 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$75.14 - $115.68 $1.91 Million - $2.94 Million
25,400 New
25,400 $2.04 Million
Q4 2019

Feb 13, 2020

SELL
$100.29 - $107.99 $708,247 - $762,625
-7,062 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$97.85 - $107.42 $691,016 - $758,600
7,062 New
7,062 $756,000
Q4 2018

Feb 14, 2019

SELL
$79.75 - $108.38 $3.62 Million - $4.92 Million
-45,398 Closed
0 $0
Q3 2018

Oct 18, 2018

BUY
$105.42 - $114.99 $4.79 Million - $5.22 Million
45,398 New
45,398 $4.9 Million
Q4 2017

Feb 12, 2018

SELL
$90.86 - $100.24 $3.03 Million - $3.35 Million
-33,398 Closed
0 $0
Q3 2017

Oct 16, 2017

BUY
$91.96 - $108.35 $3.07 Million - $3.62 Million
33,398
33,398 $3.11 Million

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Seven Eight Capital, LP Portfolio

Follow Seven Eight Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Seven Eight Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Seven Eight Capital, LP with notifications on news.